Nurse Practitioner, Family · Baton Rouge, LA
NPI
1245697994
Since 2016
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
5131 Odonovan Dr Ste 100
Baton Rouge, LA, 70808
Phone (225) 767-4893
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,073
34 services
Medicare patients, 2024
25
Average age 67
Drug cost, 2024
$1.1M
2,528 prescriptions
Company payments, 2025
$4,909
From 21 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jessica C Tran prescribed most often to Medicare patients was Auryxia (Ferric Citrate), with 291 prescriptions and refills. In total Jessica C Tran wrote 2,528 Medicare prescriptions that cost $1.1M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Auryxia Ferric Citrate | 291 | 303 | 67 | $383K |
| Losartan Potassium Generic | 205 | 461 | 74 | $1,433 |
| Furosemide Generic | 175 | 341 | 70 | $977 |
| Sevelamer Carbonate Generic | 169 | 187 | 47 | $19K |
| Velphoro Sucroferric Oxyhydroxide | 135 | 135 | 40 | $350K |
| Amlodipine Besylate Generic | 135 | 297 | 48 | $618 |
| Hydralazine Hcl Generic | 88 | 158 | 30 | $1,033 |
| Lanthanum Carbonate Generic | 84 | 84 | 25 | $73K |
| Carvedilol Generic | 71 | 159 | 28 | $727 |
| Doxazosin Mesylate Generic | 69 | 117 | 21 | $801 |
| Spironolactone Generic | 61 | 125 | 20 | $400 |
| Farxiga Dapagliflozin Propanediol | 57 | 84 | 20 | $47K |
| Jardiance Empagliflozin | 49 | 59 | 20 | $34K |
| Potassium Chloride Generic | 46 | 62 | 18 | $989 |
| Pantoprazole Sodium Generic | 45 | 73 | 14 | $315 |
Brand drugs: 695 claims; generic drugs: 1,833 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica C Tran $4,909 ($4,909 in general payments such as food, travel and fees) from 21 companies. The largest payer was Akebia Therapeutics Inc with $3,287.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 19 | $3,287 |
| Fresenius USA Marketing, Inc. | 14 | $324 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $274 |
| Vifor Pharma, Inc. | 7 | $149 |
| Amgen Inc. AMGN | 5 | $95.5 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $89.85 |
| Mallinckrodt Hospital Products Inc. | 5 | $88.85 |
| Alexion Pharmaceuticals, Inc. AZN | 4 | $83.95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79.02 |
| NxStage Medical, Inc. | 1 | $75.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.